Anti-IL1RAP antibody compositions
US12209131B2 · kind B2 · utility
0Cited by
16References
5Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Aug 15, 2019 |
| Grant date | Jan 28, 2025 |
| Priority date | — |
| Expiry date | Dec 8, 2041 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2317/92
- WIPO fieldBiotechnology
- WIPO sectorChemistry
Abstract
The present invention relates to antibody compositions directed to Interleukin 1 Receptor Accessory Protein (IL1RAP) and their use in the treatment and diagnosis of diseases associated with IL1RAP, such as inflammatory, autoimmune, autoinflammatory and neoplastic disorders.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.